Quality and Outcome Measurements of Urological Patients
Sponsor
University Hospital Inselspital, Berne (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04763538
Collaborator
Hospital Centre Biel/Bienne (Other)
2,000
1
79.9
25
Study Details
Study Description
Brief Summary
Prospectively, all available parameters of urologic patients treated at the study sites will be acquired and stored in multilayered databases. Upon a given samples size, neuronal networks will be trained to define clinical endpoints. Beside uro-oncological patients also patients with other urological diseases will be enrolled.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
2000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Quality and Outcome Measurements of Urological Patients
Anticipated Study Start Date
:
Sep 1, 2021
Anticipated Primary Completion Date
:
Apr 30, 2026
Anticipated Study Completion Date
:
Apr 30, 2028
Outcome Measures
Primary Outcome Measures
- Disease specific primary endpoint [4-5 years]
Neuronal networks will be trained to define the respective endpoints for the diseases
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- All patients treated at the study sites, signed informed consent
Exclusion Criteria:
- No consent to record medical history
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Roland Seiler | Biel | Switzerland | 2501 |
Sponsors and Collaborators
- University Hospital Inselspital, Berne
- Hospital Centre Biel/Bienne
Investigators
- Study Chair: Roland Seiler, Prof., Department of Urology, University Hospital Bern
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
University Hospital Inselspital, Berne
ClinicalTrials.gov Identifier:
NCT04763538
Other Study ID Numbers:
- ID 2020-02852
First Posted:
Feb 21, 2021
Last Update Posted:
Aug 24, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: